What does DEL PHARMA do?

DEL PHARMA is a pharmacy in Mons. General partnership, started on 25 February 2019, 1 establishment.

What is the address of DEL PHARMA?

The registered office of DEL PHARMA is located at Ch. Rive droite Canal du Centre 39, 7000 Mons.

Is DEL PHARMA still active?

Yes. According to the CBE (1 October 2026) DEL PHARMA is active, legal situation “Normale toestand”, started on 25 February 2019.

Is DEL PHARMA registered on Peppol?

Yes, DEL PHARMA is registered on the Peppol network with ID 0208:0721527966.

What is the enterprise number of DEL PHARMA?

The enterprise number of DEL PHARMA is BE0721527966.

When was DEL PHARMA founded?

DEL PHARMA was founded on 25 February 2019.

Who are the directors of DEL PHARMA?

According to the 2025 annual accounts, the directors of DEL PHARMA are: Delphine HONOREZ.

Is DEL PHARMA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 25 February 2019; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DEL PHARMA make in 2025?

DEL PHARMA posted a profit after taxes of € 5,967 in financial year 2025.

What is the revenue of DEL PHARMA?

As a small company, DEL PHARMA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 19,174.

DEL PHARMA - Mons - BE0721527966

Dossier DEL PHARMA, printed on 1 October 2026 from databakkes.be/en/0721527966/del-pharma. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DEL PHARMA from Mons, company number BE0721527966, closed financial year 2025 with a result of € 5,967 after tax. For that financial year DEL PHARMA recorded a gross margin of € 19,174 and equity of € 16,307. Compared with financial year 2024, the result moved from € 2,119 to € 5,967. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.

What it is worth Growing

€ 16,307

▲ 58% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 5,967

▲ 182% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 2,141

▲ 212% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 11,307.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Wage cost estimate Staff cost at a one-person company Staff Only people on the payroll count here.€ 81 Likely the director’s social contribution or pension premium.The director’s pay Already netted into the gross margin, not shown separately in the accounts. Typical for one-person companies € 45,000 gross per year minimum for the reduced tax rate≈ € 2,100 net per month after contributions, tax and usually some benefits in kind, roughly Assumption based on the chart of accounts, not a figure from the source.

€ 81

No payroll staff. An amount this small is usually a social contribution or pension premium for the director, booked under staff costs.

Vehicles and equipment

€ 10,074

▼ 39% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 5,982

▼ 56% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 180

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 14,224

▲ 50% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 46 Gross margin 2022: € 46 First fiscal year in the series	€ 13,826 Gross margin 2023: € 13,826 ▲ € 13,780 vs 2022 (€ 46) Favourable step	€ 13,908 Gross margin 2024: € 13,908 ▲ 1% vs 2023 (€ 13,826) Favourable step	€ 19,174 Gross margin 2025: € 19,174 ▲ 38% vs 2024 (€ 13,908) Favourable step	▲ 38%
Profit after taxes	€ -7,975 Profit after taxes 2022: € -7,975 First fiscal year in the series	€ 2,614 Profit after taxes 2023: € 2,614 ▲ € 10,589 vs 2022 (€ -7,975) Favourable step	€ 2,119 Profit after taxes 2024: € 2,119 ▼ 19% vs 2023 (€ 2,614) Unfavourable step	€ 5,967 Profit after taxes 2025: € 5,967 ▲ 182% vs 2024 (€ 2,119) Favourable step	▲ 182%
Equity	€ 5,608 Equity 2022: € 5,608 First fiscal year in the series	€ 8,221 Equity 2023: € 8,221 ▲ 47% vs 2022 (€ 5,608) Favourable step	€ 10,340 Equity 2024: € 10,340 ▲ 26% vs 2023 (€ 8,221) Favourable step	€ 16,307 Equity 2025: € 16,307 ▲ 58% vs 2024 (€ 10,340) Favourable step	▲ 58%
Total debts	€ 38,194 Total debts 2022: € 38,194 First fiscal year in the series	€ 32,533 Total debts 2023: € 32,533 ▼ 15% vs 2022 (€ 38,194) Favourable step	€ 22,975 Total debts 2024: € 22,975 ▼ 29% vs 2023 (€ 32,533) Favourable step	€ 20,636 Total debts 2025: € 20,636 ▼ 10% vs 2024 (€ 22,975) Favourable step	▼ 10%
Cash	€ 1,712 Cash 2022: € 1,712 First fiscal year in the series	€ 4,161 Cash 2023: € 4,161 ▲ 143% vs 2022 (€ 1,712) Favourable step	€ 686 Cash 2024: € 686 ▼ 84% vs 2023 (€ 4,161) Unfavourable step	€ 2,141 Cash 2025: € 2,141 ▲ 212% vs 2024 (€ 686) Favourable step	▲ 212%
Retained profit	€ 608 Retained profit 2022: € 608 First fiscal year in the series	€ 3,221 Retained profit 2023: € 3,221 ▲ € 2,614 vs 2022 (€ 608) Favourable step	€ 5,340 Retained profit 2024: € 5,340 ▲ 66% vs 2023 (€ 3,221) Favourable step	€ 11,307 Retained profit 2025: € 11,307 ▲ 112% vs 2024 (€ 5,340) Favourable step	▲ 112%
Bank debt	€ 30,352 Bank debt 2022: € 30,352 First fiscal year in the series	€ 21,970 Bank debt 2023: € 21,970 ▼ 28% vs 2022 (€ 30,352) Favourable step	€ 13,473 Bank debt 2024: € 13,473 ▼ 39% vs 2023 (€ 21,970) Favourable step	€ 5,982 Bank debt 2025: € 5,982 ▼ 56% vs 2024 (€ 13,473) Favourable step	▼ 56%
Balance sheet total	€ 43,802 Balance sheet total 2022: € 43,802 First fiscal year in the series	€ 40,754 Balance sheet total 2023: € 40,754 ▼ 7% vs 2022 (€ 43,802) Unchanged	€ 33,315 Balance sheet total 2024: € 33,315 ▼ 18% vs 2023 (€ 40,754) Unchanged	€ 36,943 Balance sheet total 2025: € 36,943 ▲ 11% vs 2024 (€ 33,315) Unchanged	▲ 11%

Key figures of DEL PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DEL PHARMA?

What happened at DEL PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 29, 2026 New annual accounts for financial year 2025: profit of € 5,967 (▲ 182% vs 2024). Source: NBB ↗
Feb 25, 2019 New establishment in Mons. KBO
Feb 25, 2019 Start of the company according to the CBE. KBO

In short

From € 7,975 loss in 2022 to € 5,967 profit in 2025.

Paid € 10,626 in corporate taxes since 2022.

Best year ever: 2025, with € 5,967 profit.

Original PDFs at the National Bank ↗

A new publication or filing at DEL PHARMA? We notify you, reason included.

Follow DEL PHARMA

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Delphine HONOREZ

DEL PHARMA

Behind DEL PHARMA is Delphine HONOREZ.

See the full network in the app

Directors

According to the 2025 annual accounts

Delphine HONOREZ

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Ch. Rive droite Canal du Centre 39

7000 Mons

2.286.683.146

Rue des Fripiers 21 box 2/1

7000 Mons

Active since 25 February 2019

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0721.527.966

VAT number

BE 0721.527.966

Registered office

Ch. Rive droite Canal du Centre 39, 7000 Mons

Names & denominations

DEL PHARMA

Enterprise type

Rechtspersoon

Legal form

General partnership

Legal situation

Normale toestand

Start date

25 February 2019

Peppol

Active · Active since 9 Sept 2026

Activities · NACE

Detailhandel in farmaceutische producten

Overige zakelijke dienstverlening, neg

View on CBE Public ↗ Annual accounts (NBB) ↗

DEL PHARMA

Financials

What happened to DEL PHARMA?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions